Recently, Xiaobian has seen a lot of news about our sanuo biology participating in the world pharmaceutical raw materials China Exhibition CPHI, and many of our partners are curious. What are the highlights beyond the news of this CPHI trip? Let Xiaobian take you back today.

Just last week, sinobio was invited to participate in the 19th CPHI. This world pharmaceutical raw materials exhibition is different from the last one. This time, it was held in Shanghai New International Expo Center, China.

So what is the scene of this world pharmaceutical raw materials exhibition in China?

Chengdu shengnuo biopharmaceutical Co., Ltd. participated in the 19th World pharmaceutical raw materials China Exhibition (CPHI)

In this exhibition, sinobio once again demonstrated our company's business profile, advanced production technology, main polypeptide and other pharmaceutical products in an all-round way for up to 3 days. At the same time, the results we show also attract many customers to visit.

In addition, in this "hundred schools of thought" exhibition site, we can also see a lot of excellent pharmaceutical company teams, they have also put out their own "housekeeping skills", showing their excellent pharmaceutical technology and advanced team facilities.

In addition to the active participation of many excellent domestic pharmaceutical companies, the participation of a number of excellent pharmaceutical company teams from the United States, Britain, Germany, France, South Korea, Turkey and other countries also highlights the great influence of CPHI.

In addition, the exhibits displayed in the exhibition are various, including APIs, intermediates and fine chemicals, excipients and dosage forms, natural extracts, biological products and other commodities and technologies. This not only shows the broad scope of the pharmaceutical industry, but also satisfies the learning desire of many enterprise teams who are constantly learning and self-motivated like our suno.

Delegation of Chengdu shengnuo bio Pharmaceutical Co., Ltd

In addition, the editor will popularize the relevant knowledge of the world pharmaceutical raw materials China Exhibition (CPHI) for you to understand your ambiguity.

Since CPHI was introduced to China in 2001, CPHI has developed rapidly with good market development opportunities, high-quality domestic and foreign audience resources and rich exhibition experience, and has become the world's leading professional trade exchange event in the vertical industry chain of the pharmaceutical industry.

This year's world pharmaceutical raw materials exhibition is sponsored by UBM EMEA and CCCMHPIE, and co organized by UBM Sinoexpo, and held in the same period with the 14th world pharmaceutical packaging equipment and materials exhibition in China.

Delegation of Chengdu shengnuo bio Pharmaceutical Co., Ltd

In addition, the exhibition also has a very user-friendly service function, which is China Pharma connect (CPC) matching system.

It can provide tailor-made online invitation service for exhibitors and visitors before the exhibition starts, help you to connect partners accurately, expand more potential business opportunities, and maximize the efficiency of the exhibition. This function has also won the praise of many domestic and foreign peers.

In the exhibition, you can learn about your own shortcomings and the advantages of others by observing each other's research and achievements.

No matter race or nationality, they learn from each other, compete with each other, share moral experience and make progress together. While promoting self-development, we will work together to carry forward the pharmaceutical industry.

Of course, sinobio also benefited a lot. In the exhibition, it not only touched the more cutting-edge and diversified product and technology development trend, but also had a deeper and rational understanding of the industry, and played a positive role in enterprise production management and production technology specifications.

In the face of the challenge of the new trend of the industry, sinobio can see the future development opportunities more clearly, and face and meet the future challenges with a more calm and confident attitude.

As a first-class professional peptide drug enterprise in China, sinobio will continue to adhere to the corporate motto of "market is the sea, quality is the ship, brand is the sail", jointly promote the development of the domestic pharmaceutical industry, strive to create a more outstanding model of the pharmaceutical industry, bear the heavy trust of the industry, and contribute more to the role of China's peptide industry in the international field.

Shengnuo bio PRODUCT

Best sales manager contact

About Shengnuo

Chengdu Shengnuo Biotechnology Co., Ltd. has "Chengdu polypeptide drug engineering technology research center" in Chengdu, mainly engaged in polypeptide, polypeptide drug and beauty peptide research. Our zero defect has passed the FDA certification, and now it has become the first-class professional peptide drug and product development, technology transfer, technical service and peptide drug industry in the scale production and export of China's parks.